EGLN1 and viral infectious disease: To further validate that EGLN1 mediates the phenotypic difference between WT and Irf3_P10A mice in response to viral infection, we used FG4592 (10 mg/kg) to block EGLN1 activity in WT and Irf3_P10A mice and then challenged them with VSV.